CEG vs SMR: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CEG and SMR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CEG and SMR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Constellation Energy (CEG) is the largest producer of carbon-free electricity in the United States, operating the country's biggest fleet of nuclear power plants alongside hydro, wind, and solar assets. Spun off from Exelon in 2022, it generates and sells power and provides energy services to commercial, industrial, government, and residential customers. Constellation's nuclear fleet produces large, steady volumes of around-the-clock, low-carbon electricity, which has become increasingly valuable as datacenters, electrification, and AI computing drive up demand for reliable clean power. The company has pursued long-term power-supply agreements with large energy buyers, including technology companies seeking carbon-free electricity for datacenters, and on January 7, 2026 closed its acquisition of Calpine, a major natural-gas and geothermal generator, which broadened its generation mix and roughly lifted trailing revenue to about $31 billion. The Justice Department required divestitures as a condition: the 606 MW Brazos Valley plant in Texas was sold to LS Power for about $860 million (closed October 14, 2026), and about 4.4 GW of mostly gas assets in Delaware and Pennsylvania are being sold to LS Power with closing expected by the end of 2026. Headquartered in Baltimore, Maryland, Constellation benefits from federal clean-energy incentives, including production tax-credit support for existing nuclear plants.

Full CEG guide

NuScale Power (SMR) is a developer of small modular nuclear reactors (SMRs), aiming to commercialize compact, factory-built reactor modules as an alternative to large conventional nuclear plants. Its flagship design is a pressurized-water reactor module that can be deployed individually or in groups to scale capacity, and it is among the few SMR designs to receive design certification or approval from the US Nuclear Regulatory Commission, a notable regulatory milestone. The pitch for SMRs is safer, more standardized, lower-upfront-cost nuclear power that can provide carbon-free, always-on baseload electricity, including for data centers and industrial users with growing power needs. NuScale is majority-affiliated with Fluor, an engineering and construction firm, and works with utility and government partners. The company is early-stage and largely pre-revenue from operating plants: it has not yet brought a commercial SMR online, and an earlier flagship deployment project was cancelled, a sign of the cost and timeline challenges. Headquartered in Portland, Oregon, NuScale is a speculative, long-horizon bet on whether small modular reactors achieve commercial scale and cost-competitiveness.

Full SMR guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CEG drivers: Datacenter and AI power demand; Nuclear fleet value and clean-energy support.
• SMR drivers: Regulatory progress and design certification; Demand for carbon-free baseload and data-center power.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Constellation has merchant exposure, so its results depend partly on wholesale power and commodity prices, which can be volatile. For SMR, nuScale is early-stage and largely pre-revenue, with about $10.7 million of trailing revenue and a trailing net loss near $416 million, so it depends on its cash (about $1.07 billion at mid-2026) and periodic capital raises that can dilute shareholders.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CEG if you believe its drivers more; SMR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CEG and SMR guides.

CEG. Constellation still trades at a higher multiple than most regulated utilities, about 27 times trailing and 21 times forward earnings, because investors price in growth from AI and datacenter power demand and the premium value of carbon-free baseload generation. The multiple has compressed in 2026 even as guidance rose and big tech contracts were signed, which leaves the stock well below the analyst mean target near $338. All figures are approximate as of October 16, 2026 and move with power prices and the share price.

SMR. NuScale cannot be valued on earnings because it has little operating revenue and runs losses; its price to sales ratio is above 200. After a roughly 88% fall over one year, the roughly $2.4 billion market value sits only a little above the company's $1.07 billion cash pile and near book value, so the market now assigns far less option value to SMR deployment than it did in late 2025. Figures are approximate and as of October 16, 2026; third-quarter results come November 5.

Headline figures (approximate, October 2026): CEG shows revenue (ttm) ~$31.3 billion (Q2 2026 up ~23% YoY with Calpine), q2 2026 adjusted operating eps $2.55 vs ~$2.28 estimate (GAAP $1.42), 2026 adjusted operating eps guidance $11.50-12.50 (raised), net income (ttm) ~$3.5 billion; SMR shows revenue (ttm) ~$10.7 million; Q2 2026 revenue ~$75,000, net loss (ttm) ~-$416 million; Q2 2026 net loss ~-$47.5 million, eps (trailing / forward) ~-$2.92 / ~-$0.66, cash / debt ~$1.07 billion / ~$7 million (June 30, 2026).

CEG and SMR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CEG and SMR exposure against your real portfolio. It is not an investment adviser.